Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial

2019129 citationsJournal Articlehybrid Open Access

Authors

British Heart Foundation, the UK Marfan Trust, the UK Marfan Association.

Good health and well-being

Published in: The Lancet

Volume 394, Issue 10216, pp. 2263-2270

Field-Weighted Citation Impact: 12.76